Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Gutteridge, W. E.
1989.
Parasite vaccines versus anti-parasite drugs: rivals or running mates?.
Parasitology,
Vol. 98,
Issue. S1,
p.
S87.
Handman, E
1990.
Study of Leishmania major-infected macrophages by use of lipophosphoglycan-specific monoclonal antibodies.
Infection and Immunity,
Vol. 58,
Issue. 7,
p.
2297.
Bjorvatn, Bjarne
and
Helland, Dag E.
1990.
Vaccinations in Health Strategies of Developing Countries: The Role of Biotechnology and Social Sciences.
Scandinavian Journal of Infectious Diseases,
Vol. 22,
Issue. sup76,
p.
1.
Nascimento, E
Mayrink, W
da Costa, C A
Michalick, M S
Melo, M N
Barros, G C
Dias, M
Antunes, C M
Lima, M S
and
Taboada, D C
1990.
Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses.
Infection and Immunity,
Vol. 58,
Issue. 7,
p.
2198.
Gutteridge, Win E.
1991.
Control of parasitic diseases: a complementary role for vaccines and drugs.
Immunology Letters,
Vol. 30,
Issue. 2,
p.
261.
Soto Mancipe, Jaime
1992.
Experiencias con vacunas contra la leishmaniasis.
Revista de las Fuerzas Armadas,
p.
109.
Moss, Jeffrey T.
and
Wilson, James P.
1992.
Current Treatment Recommendations for Leishmaniasis.
Annals of Pharmacotherapy,
Vol. 26,
Issue. 11,
p.
1452.
Brabin, Loretta
and
Brabin, Bernard J.
1992.
Advances in Parasitology Volume 31.
Vol. 31,
Issue. ,
p.
1.
Handman, Emanuela
1992.
Molecular Immunology.
Vol. 5,
Issue. ,
p.
133.
Belazzoug, S.
1992.
Leishmaniasis in Mediterranean countries.
Veterinary Parasitology,
Vol. 44,
Issue. 1-2,
p.
15.
Olobo, Joseph O.
and
Reid, Graham D.F.
1993.
Delayed-type hypersensitivity responses in vervet monkeys self-cured from experimental cutaneous leishmaniasis.
Acta Tropica,
Vol. 52,
Issue. 4,
p.
309.
Melby, P C
Andrade-Narvaez, F J
Darnell, B J
Valencia-Pacheco, G
Tryon, V V
and
Palomo-Cetina, A
1994.
Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis.
Infection and Immunity,
Vol. 62,
Issue. 3,
p.
837.
Castés, Marianella
Blackwell, Jenefer
Trujillo, Dinorah
Formica, Santina
Cabrera, Maira
Zorrilla, Gelù
Rodas, Arcady
Castellanos, Pedro Luìs
and
Convit, Jacinto
1994.
Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-γ production.
Vaccine,
Vol. 12,
Issue. 11,
p.
1041.
Koff, Amy Beth
and
Rosen, Theodore
1994.
Treatment of cutaneous leishmaniasis.
Journal of the American Academy of Dermatology,
Vol. 31,
Issue. 5,
p.
693.
Aebischer, T.
1994.
Recurrent cutaneous leishmaniasis: A role for persistent parasites?.
Parasitology Today,
Vol. 10,
Issue. 1,
p.
25.
Magill, Alan J.
1995.
Epidemiology of the Leishmaniases.
Dermatologic Clinics,
Vol. 13,
Issue. 3,
p.
505.
Hommel, M.
Jaffe, C. L.
Travi, B.
and
Milon, G.
1995.
Experimental models for leishmaniasis and for testing anti-leishmanial vaccines.
Annals of Tropical Medicine & Parasitology,
Vol. 89,
Issue. sup1,
p.
55.
Schnur, Lionel F.
and
Greenblatt, Charles L.
1995.
Parasitic Protozoa.
p.
1.
Dubois, P.
and
Pereira da Silva, L.
1995.
Towards a vaccine against asexual blood stage infection by Plasmodium falciparum.
Research in Immunology,
Vol. 146,
Issue. 4-5,
p.
263.
Sousa, Claris B. Palatnik de
Gomes, Elza M.
Souza, Edilma Paraguai de
Santos, Wania R. dos
Macedo, Sirley R. de
Medeiros, Linnete V. de
and
Luz, Kleber
1996.
The FML (Fucose Mannose Ligand) of Leishmania donovani: a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar.
Revista da Sociedade Brasileira de Medicina Tropical,
Vol. 29,
Issue. 2,
p.
153.